Reimagining Druggability

We are reimagining druggability using chemoproteomic platforms to develop transformative medicines.

Explore more


One of the greatest challenges that we face in discovering new disease therapies is that most proteins are considered “undruggable.” Our research group is reimagining druggability by using chemoproteomic approaches to tackle the undruggable proteome.

Meet Our Team

We are a group of highly motivated scientists with a desire to engage in multidisciplinary research at the interface of chemistry and biology.

Latest News


Our work on SARS-CoV-2 and our recent MYC inhibitor story highlighted by Mark Foundation for Cancer Research

Congrats to recent MCB-chemical biology Ph.D. graduate Carl Ward for being co-awarded the Nicholas Cozzarelli Prize!!

The Nicholas Cozzarelli Prize is awarded to MCB PhD graduates for their exceptional graduate dissertation research.

Congrats to chemical biology graduate student Jessica Spradlin for being awarded the NCI F99/K00 Predoctoral to Postdoctoral Transition Award!!

Jessica was previously an NCI F31 predoctoral fellowship recipient. The NCI Predoctoral to Postdoctoral Fellow Transition (F99/K00) Award supports outstanding Ph.D. and other Research Doctoral candidates complete…

Help us advance
our research